Extendicare (EXE) Stock Price, News & Analysis

Company Overview

Extendicare Inc., operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Key Stats

• Today's Range: C$31.67 to C$34.14
• 50-Day Range: C$25.40 to C$33.44
• 52-Week Range: C$12.12 to C$35.62
• Volume: 536,199 shs
• Average Volume: 320,640 shs
• Market Capitalization: C$3.00 billion
• P/E Ratio: 28.58
• Dividend Yield: 1.57%
• Price Target: C$30.44
• Consensus Rating: Buy

Extendicare Stock Analysis - MarketRank™

Extendicare scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Buy

Consensus Rating

Extendicare has received a consensus rating of Buy. The company's average rating score is 3.14, and is based on 1 strong buy rating, 6 buy ratings, no hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Extendicare is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Extendicare has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Extendicare is 28.58, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.20.

Price to Earnings Ratio vs. Sector

The P/E ratio of Extendicare is 28.58, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.87.

Price to Book Value per Share Ratio

Extendicare has a P/B Ratio of 7.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for EXE.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Extendicare pays a meaningful dividend of 1.75%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Extendicare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Extendicare is 44.92%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.42

News Sentiment

Extendicare has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Extendicare this week, compared to 1 article on an average week.

Search Interest

35 people have searched for EXE on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Extendicare insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

21.00% of the stock of Extendicare is held by institutions.

Company Calendar

• Ex-Dividend for 5/15 Dividend: 4/30/2026
• Last Earnings: 5/07/2026
• Today: 5/11/2026
• Record date for 5/15 Dividend: 5/15/2026
• Dividend Payable: 5/15/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: TSE:EXE
• CIK: N/A
• Web: www.extendicare.com
• Phone: 905-470-4000
• Fax: N/A
• Employees: 23,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Extendicare: C$30.44
• High Price Target: C$39.00
• Low Price Target: C$22.50
• Potential Upside/Downside: -4.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.14
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): C$1.11
• Trailing P/E Ratio: 28.58
• Forward P/E Ratio: 51.85
• P/E Growth: N/A
• Net Income: C$65.46 million
• Net Margins: 6.99%
• Pretax Margin: N/A
• Return on Equity: 45.35%
• Return on Assets: 7.16%

Debt

• Debt-to-Equity Ratio: 82.55
• Current Ratio: 1.44
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: C$1.75 billion
• Price / Sales: 1.72
• Cash Flow: C$9.93 per share
• Price / Cash Flow: 3.20
• Book Value: C$4.12 per share
• Price / Book: 7.72

Miscellaneous

• Outstanding Shares: 94,458,000
• Free Float: N/A
• Market Cap: C$3.00 billion
• Optionable: Not Optionable
• Beta: 1.27